- Home
- DRIO vs VINC Comparison
DRIO vs VINC Comparison
Compare DRIO & VINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- VINC
- Stock Information
- Founded
- DRIO 2011
- VINC 2019
- Country
- DRIO United States
- VINC United States
- Employees
- DRIO N/A
- VINC N/A
- Industry
- DRIO Medical/Dental Instruments
- VINC Biotechnology: Pharmaceutical Preparations
- Sector
- DRIO Health Care
- VINC Health Care
- Exchange
- DRIO Nasdaq
- VINC Nasdaq
- Market Cap
- DRIO 25.1M
- VINC 23.2M
- IPO Year
- DRIO N/A
- VINC N/A
- Fundamental
- Price
- DRIO $1.13
- VINC $0.73
- Analyst Decision
- DRIO Strong Buy
- VINC Buy
- Analyst Count
- DRIO 1
- VINC 1
- Target Price
- DRIO $4.00
- VINC N/A
- AVG Volume (30 Days)
- DRIO 123.1K
- VINC 142.6K
- Earning Date
- DRIO 10-31-2024
- VINC 11-12-2024
- Dividend Yield
- DRIO N/A
- VINC N/A
- EPS Growth
- DRIO N/A
- VINC N/A
- EPS
- DRIO N/A
- VINC N/A
- Revenue
- DRIO $19,147,000.00
- VINC N/A
- Revenue This Year
- DRIO $36.40
- VINC N/A
- Revenue Next Year
- DRIO $35.93
- VINC N/A
- P/E Ratio
- DRIO N/A
- VINC N/A
- Revenue Growth
- DRIO N/A
- VINC N/A
- 52 Week Low
- DRIO $0.68
- VINC $0.51
- 52 Week High
- DRIO $3.32
- VINC $9.37
- Technical
- Relative Strength Index (RSI)
- DRIO 62.33
- VINC 53.42
- Support Level
- DRIO $0.95
- VINC $0.67
- Resistance Level
- DRIO $1.16
- VINC $0.73
- Average True Range (ATR)
- DRIO 0.09
- VINC 0.05
- MACD
- DRIO 0.02
- VINC -0.00
- Stochastic Oscillator
- DRIO 89.80
- VINC 56.45
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About VINC Vincerx Pharma Inc.
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.